Well i will be working for Takeda come Jan 8th when the buyout of Shire closes...so i will try to get AVXL on their radar—although i doubt they will be doing any more deals in the near future after shelling out $66 Billion for Shire and going into massive debt through this acquisition.
Agree Eisai or Tekeda are great potential partners. cover the huge Japanese aging population and Japanese docs like to prescribe drugs. plus both comapanies have a history of paying FAT prices for companies and partners they want